Literature DB >> 30637566

Regulation of CCl4-induced liver cirrhosis by hepatically differentiated human dental pulp stem cells.

Tomomi Yokoyama1, Hiromi Yagi Mendoza1, Tomoko Tanaka1, Hisataka Ii1, Riya Takano1, Ken Yaegaki2, Hiroshi Ishikawa1,3.   

Abstract

Liver transplantation is the most effective treatment for treating liver cirrhosis. However, a limited number of donors, graft rejection, and other complications can undermine transplant success. It is considered that cell transplantation is an alternative approach of liver transplantation. We previously developed a protocol for hepatic differentiation of cluster of differentiation 117+ stem cells isolated from human exfoliated deciduous tooth pulp (SHEDs) under hydrogen sulfide exposure. These cells showed excellent hepatic function. Here, we investigated whether hepatocyte-like cell transplantation is effective for treating carbon tetrachloride (CCl4)-induced liver cirrhosis. SHEDs were hepatically differentiated, which was confirmed via immunological analyses and albumin concentration determination in the medium. Rats were intraperitoneally injected with CCl4 for and the differentiated cells were injected into rat spleen. Histopathological and immunohistochemical analyses were performed. Liver functions were serologically and pathologically determined. Quantitative real-time-polymerase chain reaction was implemented to clarify the treatment procedure of liver cirrhosis. In vitro-differentiated hepatocyte-like cells were positive for all examined hepatic markers. SHED-derived hepatocyte transplantation eliminated liver fibrosis and restored liver structure in rats. Liver immunohistochemical analyses showed the presence of human-specific hepatic markers, i.e., a large amount of human hepatic cells were very active in the liver and spleen. Serological tests revealed significant liver function recovery in the transplantation group. Expression of genes promoting fibrosis increased after cirrhosis induction but was suppressed after transplantation. Our results suggest that xenotransplantation of hepatocyte-like cells of human origin can treat cirrhosis. Moreover, cell-based therapy of chronic liver conditions may be an effective option.

Entities:  

Keywords:  Cell transplantation; Hepatic differentiation; Hydrogen sulfide; Liver cirrhosis; Tooth pulp stem cells

Mesh:

Substances:

Year:  2019        PMID: 30637566     DOI: 10.1007/s13577-018-00234-0

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  3 in total

1.  Stem Cells From Human Exfoliated Deciduous Teeth Alleviate Liver Cirrhosis via Inhibition of Gasdermin D-Executed Hepatocyte Pyroptosis.

Authors:  Peng Chen; Yi-Kun Zhou; Chun-Shan Han; Liu-Jing Chen; Yi-Ming Wang; Zi-Meng Zhuang; Shuai Lin; Yan-Heng Zhou; Jiu-Hui Jiang; Rui-Li Yang
Journal:  Front Immunol       Date:  2022-05-12       Impact factor: 8.786

2.  Long noncoding RNA SNHG1 silencing accelerates hepatocyte-like cell differentiation of bone marrow-derived mesenchymal stem cells to alleviate cirrhosis via the microRNA-15a/SMURF1/UVRAG axis.

Authors:  Jia Sun; Xuedong Sun; Sean Hu; Maoqiang Wang; Na Ma; Junhui Chen; Feng Duan
Journal:  Cell Death Discov       Date:  2022-02-22

Review 3.  Odontogenic MSC Heterogeneity: Challenges and Opportunities for Regenerative Medicine.

Authors:  Yuan Chen; Zhaoyichun Zhang; Xiaoxue Yang; Anqi Liu; Shiyu Liu; Jianying Feng; Kun Xuan
Journal:  Front Physiol       Date:  2022-04-19       Impact factor: 4.755

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.